Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.310
-0.070 (-2.94%)
Oct 5, 2026, 10:44 AM EDT - Market open
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $451.14 million as of October 5, 2026. Its market cap has increased by 244.91% in one year.
Market Cap
451.14M
Enterprise Value
294.08M
1-Year Change
244.91%
Ranking
Category
Stock Price
$2.31
ChartMarket Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has increased from $301.40M to $451.14M, an increase of 49.68%. That is a compound annual growth rate of 4.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 451.14M | 288.58% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 495.19M |
| Contineum Therapeutics | 493.59M |
| Puma Biotechnology | 490.91M |
| REGENXBIO | 490.48M |
| Bright Minds Biosciences | 488.45M |
| Arvinas | 484.51M |
| Eupraxia Pharmaceuticals | 477.13M |
| Autolus Therapeutics | 473.77M |